March 20, 2019
Acertitude Recruits New President to Scale Solmetex
Solmetex strengthens leadership to take on the next stage in the company’s growth journey together with private equity firm AVALT
NEW YORK (Mar. 20, 2019) — Acertitude, the executive search firm unleashing human potential, has recruited Kevin Danahy into the new role of president at Solmetex, a leading global provider of amalgam separation technology and dental waste management solutions. The company is sponsored by private equity firms AVALT, Gemini Investors, and Riviera Investment Group.
Danahy brings more than 17 years of global leadership experience in accelerating revenue growth and building high-performance teams to drive long-term success. He joins Solmetex from medical device manufacturer Zimmer Biomet, where he served as vice president of global emerging technologies and specialty sales. He previously progressed through sales leadership roles with Intuitive Surgical, Medtronic, and Ortho-McNeil Pharmaceutical.
As new legislation goes into effect — requiring U.S. dental offices to use amalgam separators by 2020 — Solmetex is gearing up for organic growth due to rising customer demand. The company already leads its industry, thanks in part to its dominant product called the Hg5 Amalgam Separator.
Reporting directly to CEO Nick Mozzicato, Danahy will lead the overall strategy for Solmetex. Danahy will scale sales, marketing, operations, engineering, and service while ensuring operational excellence across the company. He is also charged with developing and executing innovative, scalable solutions that will be instrumental in transitioning the fast-growing company to the next level.
“We are an organization that is focused on implementing green products into the dental industry to assist dentists with best management practices to deal with their waste streams,” Mozzicato said. “As dental offices work to achieve compliance with mercury removal, we want to solve this problem on a bigger scale. Kevin is a great fit to lead our efforts. He is a strong leader with an excellent track record of building medical device organizations. I am excited to keep the momentum of our growth going together.”
Acertitude Managing Partner Kevin O’Neill and Partner Geoff Votta completed the president search by collaborating closely with Mozzicato and Mark Verdi, partner at AVALT.
“Solmetex is a great business built by great people,” O’Neill said. “As demand for the company’s products increases, it is in a position to continue to deliver and innovate with Kevin on the team. He is bright, capable, and experienced. We look forward to seeing him unleash the company’s full potential.”
Verdi added: “Solmetex holds a strong competitive position in a growth market. Investing in the right leaders is key to accelerating the company’s growth. We couldn’t be happier with the addition of Kevin, and we thank Acertitude for finding us an extraordinary president.”
Acertitude is the executive search firm unleashing human potential. We discover, connect, and empower brilliant people at work. Our approach to search creates human connections, uses sophisticated data and behavioral analytics, and brings your inside story to life. Our team specializes in the consumer, financial, healthcare and life sciences, industrial, private equity, professional services, and technology industries. Explore how to unleash your potential: www.acertitude.com.
Media inquiries: For additional information, please contact Linnéa Jungnelius, Senior Director, Marketing + Strategy at Acertitude: firstname.lastname@example.org.